Skip to content

Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -

Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02021448
Enrollment
188
Registered
2013-12-27
Start date
2013-12-31
Completion date
2022-06-30
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturnal Alveolar Hypoventilation, Obesity-hypoventilation Syndrome

Keywords

OHS

Brief summary

Investigate whether the course of an isolated nocturnal alveolar hypoventilation can predict the future occurrence of obesity-hypoventilation syndrome (OHS) in obese subjects

Interventions

OTHERAnnual visits among 3 years. During each visit different testings are performed in order to detect an obesity-hypoventilation syndrome (OHS)

Polygraphy/Polysomnography,Blood sampling, EKG,Lung function testing,Arterial blood gases,Thoracic radiography,Six-minute walk test,Respiratory questionnaires

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Obese volunteer Subject (BMI\> 30 kg/m2) * Adults of either sex * Social security affiliation * Written informed consent

Exclusion criteria

* Confirmed OHS at baseline defined by a daytime hypercapnia with PaCO2\> 45mmHg * Any cause of chronic respiratory failure other than obesity such as COPD, chest deformation, phrenic nerve paralysis, pulmonary fibrosis, neuromuscular disease, a history of mutilating thoracic surgery ... * Obstructive ventilatory defect with FEV1/ FVC \<70% post-bronchodilator * Long term oxygen therapy, noninvasive ventilation, continuous positive airway pressure * Any serious illness involving life-threatening within 3 years after inclusion * Drug or alcohol abuse * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of obesity-hypoventilation syndrome3 yearspartial pressure of carbon dioxide in the arterial blood \> 45mmHg

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026